Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Glucagon Response in T1D
NCT06881459Completed
- Sponsor
- Gentofte Hospital
- Start
- Mar 2025
- Primary completion
- Jul 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial in type 1 diabetes mellitus (T1D) comparing Infusion of placebo with Infusion of oxytocin (2 arms). Primary endpoint: Glucagon secretion. Started Mar 2025; status: completed.
02
Drugs
oxytocin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06881459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06881459.